References
- Ekström-Smedby K, Vajdic CM, Falster M, Engelas EA, Martinez-Maza O, Turner J, . Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: A pooled analysis within the InterLymph Consortium. Blood 2008;111:4029–38.
- Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: Clinical and pathophysiologic aspects. Medicine (Baltimore) 2009;88: 284–93.
- Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: Risks, management and prognosis. Rheum Dis Clin North Am 2008;34: 921–33.
- Hellgren K, Smedby KE, Feltelius N, Baecklund E, Askling J. Do rheumatoid arthritis and lymphoma share risk factors?: A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis. Arthritis Rheum 2010;62:1252–8.
- Vujasinovic-Stupar N, Pejnovic N, Markovic O, Babic G. Influence of rituximab-CHOP therapy on clinical course and autoimmune parameters in rheumatoid arthritis associated with diffuse large B cell non-Hodgkin lymphoma. Ann Hematol 2008;87:767–9.
- Tsang HH, Trendell-Smith NJ, Wu AK, Mok MY. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus. Lupus 2010;19:330–3.
- O'Neill BP, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol 2007;9:364–9.
- Dasgupta N, Gelber AC, Racke F, Fine DM. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis. Lupus 2005;14:910–3.
- Finelli PF, Naik K, Digiuseppe JA, Prasad A. Primary lymphoma of CNS, mycophenolate mofetil and lupus. Lupus 2005;15:886–8.
- Jahnke K, Thiel E. Treatment options for central nervous system lymphomas in immunocompetent patients. Expert Rev Neurother 2009;9:1497–509.
- Algazi AP, Kadoch C, Rubenstein JL. Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 2009;6:587–97.
- Shah GD, Yahalom J, Corea DD, Lai RK, Deangelis LM, Abrey LE, . Combined immunochemotherapy with reduced dose whole-brain radiotherapy for newly diagnosed patients with primary CNS lymphoma. J Clin Oncol 2007;25: 4730–5.
- Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, . Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent intraocular lymphoma. J Clin Oncol 2008;26:2512–8.
- Krance R, Brenner M. BMT beats autoimmune disease. Nature Medicine 1998;4:153–5.
- Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome – an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006;33:2178–83.